Trade Summary

1 week ago, Patel Snehal, serving as CEO and CFO at Greenwich LifeSciences, Inc. (GLSI), purchased 2,200 shares at $13.43 per share, for a total transaction value of $29,555.00. Following this transaction, Patel Snehal now holds 5,611,402 shares of GLSI.

This purchase represents a 0.04% increase in Patel Snehal's stake in the company.

The trade was executed on Tuesday, July 28, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, July 30, 2026 at 6:05 AM ET, 2 days after the trade was made.

Greenwich LifeSciences, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.